About: Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS) Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 May 1995

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 1995 (uk) im Mai 1995 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en mayu de 1995 (ast) scientific article published on 01 May 1995 (en) գիտական հոդված հրատարակված 1995 թվականի մայիսի 1-ին (hy)
publication date	wds:Q72220309-658AF912-C04A-40EC-A4B3-30F70956F331
publication date	1995-05-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q72220309-9E4F7F44-8F3B-40ED-861D-42B035E13D96
language of work or name	English
author name string	wds:Q72220309-04EFBBFA-68BE-494C-AED9-7785D1A2081A wds:Q72220309-109EEE4F-93A8-4202-B992-2516BAE9157C wds:Q72220309-3F346395-12B4-4D1B-B208-E79F66982215 wds:Q72220309-6638F90B-EB5F-4C19-97A9-131153322B2E wds:Q72220309-7539B9BF-9050-46F8-8276-B5244F9A2BEC wds:Q72220309-796F68FB-7652-4DBE-B39C-619CC8FBF2F4 wds:Q72220309-CE8E677F-0A6E-491B-A5DC-B4633288CDBD wds:Q72220309-DBDDB65E-9B85-42A9-A776-1C1A54C49DE3 wds:Q72220309-ECF36C8B-65D0-4253-B1D0-FB913BD3BFA4 wds:Q72220309-F0446EDA-C14A-43C6-A486-4046B6B7BA6B
author name string	A V Bruschke E T Bal K I Lie A H Zwinderman J W Jukema H Jansen J H Reiber A J van Boven G J Boerma F M van Rappard
rdfs:label	Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS) (en) Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (nl)
skos:prefLabel	Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS) (en) Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (nl)
name	Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS) (en) Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (nl)
title	wds:Q72220309-27633BC4-4C33-4D4E-ACE1-D370DDD89642
title	Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS) (en)
page(s)	wds:Q72220309-25B62DD1-42D0-44E0-A4BE-5D035B33D3EF
page(s)	2528-2540
instance of	wds:Q72220309-F64374C7-47A6-47C7-A5F1-F566D1D25CD6
instance of	scholarly article
main subject	wds:Q72220309-71F9A032-7EDE-46EA-827E-BFF10F6F4708
main subject	coronary artery disease
PubMed ID	wds:Q72220309-A7C58E42-661A-472B-AA95-48EA6DE69EED
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7743614
PubMed ID	7743614
published in	wds:Q72220309-92829010-56DF-4AFE-8A4F-89758D037C16
published in	Circulation
issue	wds:Q72220309-E553B813-C640-41CC-A234-1452171D1C5F
volume	wds:Q72220309-71F63997-FE4C-4B92-AB8C-E4EF344373E7
issue	10
volume	91
DOI	wds:Q72220309-6DE60A7E-0B81-4C96-B700-0DDB500647C1
DOI	http://dx.doi.org/10.1161/01.CIR.91.10.2528
DOI	10.1161/01.CIR.91.10.2528
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q72220309
is cites work of	HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials data Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors Clinically relevant differences between the statins: implications for therapeutic selection Thematic review series: patient-oriented research. Imaging atherosclerosis: state of the art. Physician extenders for cost-effective management of hypercholesterolemia. Statin treatment and progression of atherosclerotic plaque burden Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes The Lipoprotein and Coronary Atherosclerosis Study (LCAS): design, methods, and baseline data of a trial of fluvastatin in patients without severe hypercholesterolemia Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progression of coronary artery disease in the Bezafibrate Coronary Atherosclerosis Intervention Tr Design features and baseline characteristics of the LIPID (long-term intervention with pravastatin in ischemic disease) study: A randomized trial in patients with previous acute myocardial infarction and/or unstable angina pectoris Design, rationale, and baseline characteristics of the Prospective Pravastatin Pooling (PPP) project—A combined analysis of three large-scale randomized trials: Long-Term Intervention With Pravastatin in Ischemic Disease (LIPID), Cholesterol and Re Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study) Novel HDL-directed pharmacotherapeutic strategies Combined antihypertensive and lipid-lowering treatment All cholesterol-lowering interventions are expected to reduce stroke: Confirmatory data from IMPROVE-IT. Effect of pravastatin on progression and regression of coronary atherosclerosis and vessel wall changes in carotid and femoral arteries: a report from the Regression Growth Evaluation Statin Study Effect of pravastatin on angiographic restenosis after coronary balloon angioplasty. The PREDICT Trial Investigators. Prevention of Restenosis by Elisor after Transluminal Coronary Angioplasty New insights into the pharmacodynamic and pharmacokinetic properties of statins. Effective management of hypertension with dihydropyridine calcium channel blocker-based combination therapy in patients at high cardiovascular risk A novel functional polymorphism in the PECAM-1 gene (53G>A) is associated with progression of atherosclerosis in the LOCAT and REGRESS studies. The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study A study to determine the response of coronary atherosclerosis to raising low high density lipoprotein cholesterol with a fibric-acid derivative in men after coronary bypass surgery. The rationale, design, and baseline characteristics of the LOCAT St Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention Efficacy of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in the treatment of patients with hypercholesterolemia: a meta-analysis of clinical trials Platelet-endothelial interactions in atherothrombotic disease: therapeutic implications. Drug Insight: using statins to treat neuroinflammatory disease The complex interplay between cholesterol and prostate malignancy Cholesteryl ester transfer protein concentration is associated with progression of atherosclerosis and response to pravastatin in men with coronary artery disease (REGRESS). The evolving role of statins in the management of atherosclerosis Effects of simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular disease Efficacy and safety of cerivastatin and pravastatin in the treatment of primary hypercholesterolemia Pravastatin therapy in hyperlipidemia: effects on thrombus formation and the systemic hemostatic profile Statin therapy decreases myocardial function as evaluated via strain imaging The Lescol ® Intervention Prevention Study (LIPS): a double-blind, placebo-controlled, randomized trial of the long-term effects of fluvastatin after successful transcatheter therapy in patients with coronary heart disease Targeting tumor cell metabolism with statins. Role of fibrates in the management of hypertriglyceridemia Measurement of carotid intima-media thickness to assess progression and regression of atherosclerosis Metabolic modes of action of the statins in the hyperlipoproteinemias American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease Intravascular ultrasound evaluation of coronary plaque regression by low density lipoprotein-apheresis in familial hypercholesterolemia: the Low Density Lipoprotein-Apheresis Coronary Morphology and Reserve Trial (LACMART). A novel therapeutic effect of statins on nephrogenic diabetes insipidus Benefit of aggressive lipid-lowering therapy: insights from the post coronary artery bypass graft study and other trials.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software